|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 35/00 | |
| A61K 31/506 | |||
| C07D 239/48 |
| (11) | Patento numeris | 2825041 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13760923.6 |
| Europos patento paraiškos padavimo data | 2013-03-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-01-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/030982 |
| Data | 2013-03-13 |
| (87) | Numeris | WO 2013/138495 |
| Data | 2013-09-19 |
| (30) | Numeris | Data | Šalis |
| 201261611376 P | 2012-03-15 | US |
| (72) |
LAI, Mei, US
|
| (73) |
Celgene CAR LLC,
AON House 30 Woodbourne Avenue, Pembroke HM 08,
BM
|
| (54) | SOLID FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR |
| SOLID FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR |